M&As this week: UCB Pharma, China Meheco

8th June 2017 (Last Updated June 8th, 2017 18:30)

Beryllium Discovery has become a fully owned subsidiary of UK-based pharmaceutical company UCB Pharma, with the latter acquiring the remaining stake in the former.

Beryllium Discovery has become a fully owned subsidiary of UK-based pharmaceutical company UCB Pharma, with the latter acquiring the remaining stake in the former.

"China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province."

The target company is a drug discovery contract research organisation.

The acquirer company expects the acquisition to help grow its pipeline.

China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province.

The purchase consideration for the transaction is expected to be CNY286.2m ($42.05m).